Found: 8
Select item for more details and to access through your institution.
Trends in survival and cure after allogeneic haematopoietic cell transplantation for acute myeloid leukaemia from 2000 to 2020: A Danish population‐based cohort study.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 4, p. e40, doi. 10.1111/bjh.18511
- By:
- Publication type:
- Article
Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation ( EBMT).
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 4, p. 521, doi. 10.1111/bjh.14791
- By:
- Publication type:
- Article
15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial ( MCL2): prolonged remissions without survival plateau.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 3, p. 410, doi. 10.1111/bjh.14241
- By:
- Publication type:
- Article
Pulmonary function is a strong predictor of 2‐year overall survival and non‐relapse mortality after allogenic hematopoietic cell transplantation.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 1, p. 50, doi. 10.1111/ejh.13869
- By:
- Publication type:
- Article
Single-institution long-term outcomes for patients receiving nonmyeloablative conditioning hematopoeitic cell transplantation for chronic lymphocytic leukemia and follicular lymphoma.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 2, p. 151, doi. 10.1111/j.1600-0609.2012.01801.x
- By:
- Publication type:
- Article
Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant.
- Published in:
- European Journal of Haematology, 2003, v. 71, n. 2, p. 73, doi. 10.1034/j.1600-0609.2003.00093.x
- By:
- Publication type:
- Article
Error in a study of the outcome of mantle cell lymphoma: Nordic MCL2 Trial Update: 6-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 6, p. 815, doi. 10.1111/bjh.12006
- By:
- Publication type:
- Article
Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 3, p. 355, doi. 10.1111/j.1365-2141.2012.09174.x
- By:
- Publication type:
- Article